These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 16128272)
21. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines. Tunheim G; Arnemo M; Næss LM; Fjeldheim ÅK; Nome L; Bolstad K; Aase A; Mandiarote A; González H; González D; García L; Cardoso D; Norheim G; Rosenqvist E Vaccine; 2013 Dec; 31(51):6097-106. PubMed ID: 24120679 [TBL] [Abstract][Full Text] [Related]
22. Meningococcal Serogroup A, B, C, W, X, and Y Serum Bactericidal Antibody Assays. Lucidarme J; Louth J; Townsend-Payne K; Borrow R Methods Mol Biol; 2019; 1969():169-179. PubMed ID: 30877677 [TBL] [Abstract][Full Text] [Related]
23. A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines. Reyes F; Otero O; Camacho F; Amin N; Ramírez F; Valdés Y; Acevedo R; García L; Cardoso D; Cuello M Biologicals; 2014 Nov; 42(6):312-5. PubMed ID: 25218518 [TBL] [Abstract][Full Text] [Related]
24. Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination. van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM Vaccine; 2017 Aug; 35(36):4753-4760. PubMed ID: 28647167 [TBL] [Abstract][Full Text] [Related]
25. Global epidemiology of meningococcal disease and vaccine efficacy. Pollard AJ Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S274-9. PubMed ID: 15597069 [TBL] [Abstract][Full Text] [Related]
26. Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients. Wyplosz B; Derradji O; Hong E; François H; Durrbach A; Duclos-Vallée JC; Samuel D; Escaut L; Launay O; Vittecoq D; Taha MK Transpl Infect Dis; 2015 Apr; 17(2):322-7. PubMed ID: 25645691 [TBL] [Abstract][Full Text] [Related]
28. Impact of vaccination on meningococcal epidemiology. Stefanelli P; Rezza G Hum Vaccin Immunother; 2016 Apr; 12(4):1051-5. PubMed ID: 26512927 [TBL] [Abstract][Full Text] [Related]
29. Safety and immunogenicity of meningococcal ACWY CRM197-conjugate vaccine in children, adolescents and adults in Russia. Ilyina N; Kharit S; Namazova-Baranova L; Asatryan A; Benashvili M; Tkhostova E; Bhusal C; Arora AK Hum Vaccin Immunother; 2014; 10(8):2471-81. PubMed ID: 25424958 [TBL] [Abstract][Full Text] [Related]
30. Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine in healthy adolescents in Korea--A randomised trial. Lee HJ; Choe YJ; Hong YJ; Kim KH; Park SE; Kim YK; Oh CE; Lee H; Song H; Bock H; Casula D; Bhusal C; Arora AK Vaccine; 2016 Feb; 34(9):1180-6. PubMed ID: 26826544 [TBL] [Abstract][Full Text] [Related]
31. Prevention of Meningococcal Infection in the United States: Current Recommendations and Future Considerations. Baker CJ J Adolesc Health; 2016 Aug; 59(2 Suppl):S29-37. PubMed ID: 27449147 [TBL] [Abstract][Full Text] [Related]
32. Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa. Acevedo R; Zayas C; Norheim G; Fernández S; Cedré B; Aranguren Y; Cuello M; Rodriguez Y; González H; Mandiarote A; Pérez M; Hernández M; Hernández-Cedeño M; González D; Brorson SH; Rosenqvist E; Naess L; Tunheim G; Cardoso D; García L Pharmacol Res; 2017 Jul; 121():194-201. PubMed ID: 28495657 [TBL] [Abstract][Full Text] [Related]
33. Immunogenicity and safety of a meningococcal serogroup A, C, Y and W glycoconjugate vaccine, ACWY-TT. Findlow H; Borrow R Adv Ther; 2013 May; 30(5):431-58. PubMed ID: 23712402 [TBL] [Abstract][Full Text] [Related]
34. Serologic correlates of protection for evaluating the response to meningococcal vaccines. Balmer P; Borrow R Expert Rev Vaccines; 2004 Feb; 3(1):77-87. PubMed ID: 14761245 [TBL] [Abstract][Full Text] [Related]
35. A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial. Block SL; Szenborn L; Daly W; Jackowska T; D'Agostino D; Han L; Dull PM; Smolenov I Vaccine; 2015 May; 33(21):2500-10. PubMed ID: 25795256 [TBL] [Abstract][Full Text] [Related]
36. Towards an improved serogroup B Neisseria meningitidis vaccine. Perrett KP; Pollard AJ Expert Opin Biol Ther; 2005 Dec; 5(12):1611-25. PubMed ID: 16318425 [TBL] [Abstract][Full Text] [Related]
37. Meningococcal disease: risk for international travellers and vaccine strategies. Wilder-Smith A Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105 [TBL] [Abstract][Full Text] [Related]
38. Meningococcal disease and vaccination in North America. Pollard AJ; Scheifele D J Paediatr Child Health; 2001 Oct; 37(5):S20-7. PubMed ID: 11885732 [TBL] [Abstract][Full Text] [Related]